Skip to main content
SpringerLink
Log in

Ischemic Optic Neuropathies: Update

  • Chapter
  • First Online:
Neuro-ophthalmic Disorders

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 585 Accesses

Abstract

Compromised blood supply to the optic nerve with concurrent ischemic damage is a common cause of optic neuropathy and has many variants. This chapter focuses on this entity and its types. A brief description of the relevant clinical anatomy is included along with a short description of the pertinent points to be considered during history taking and clinical examination of these patients. Nonarteritic anterior ischemic optic neuropathy (NAION), which is the commonest type of ischemic optic neuropathy, is discussed in detail—including clinical features, investigations, and recent advances and trials for the management of this entity. A complete review of arteritic ischemic optic neuropathy—associated with giant cell arteritis (GCA)—is also included including management of the acute episode and long-term management. Less common variants such as posterior ischemic optic neuropathy (PION) are also discussed to provide a complete overview of the topic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kupfer C, Chumbly L, Downer JC. Quantitative histology of optic nerve tract and lateral geniculate nucleus of man. J Anat. 1967;101:393–401.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Potts AM, Hodges D, Sherman CB, et al. Morphology of the primate optic nerve: I-III. Invest Ophthalmol Vis Sci. 1972;11:980–1016.

    CAS  Google Scholar 

  3. Hayreh SS. The 1994 Van Sallman Lecture: the optic nervehead circulation in health and disease. Exp Eye Res. 1995;61:259–72.

    Article  CAS  PubMed  Google Scholar 

  4. Onda E, Cioffi GA, Bacon DR, et al. Microvasculature of the human optic nerve. Am J Ophthalmol. 2008;43:308–12.

    Google Scholar 

  5. Johnson LN, Arnold AC. Incidence of nonarteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994;14:38–44.

    Article  CAS  PubMed  Google Scholar 

  6. Arnold AC, et al. The spectrum of optic disc ischemia in patients younger than 50 years. Trans Am Ophthalmol Soc. 2013;111:93–118.

    PubMed  PubMed Central  Google Scholar 

  7. Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103–7.

    Article  CAS  PubMed  Google Scholar 

  8. Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766–80.

    Article  CAS  PubMed  Google Scholar 

  9. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol. 1997;115:1403–7.

    Article  CAS  PubMed  Google Scholar 

  10. Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366–74.

    Article  Google Scholar 

  11. Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol. 1997;124:641–7.

    Article  CAS  PubMed  Google Scholar 

  12. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213:76–96.

    Article  CAS  PubMed  Google Scholar 

  13. Doro S, Lessell S. Cup disc ratio and ischemic optic neuropathy. Arch Ophthalmol. 1993;103:1143–4.

    Article  Google Scholar 

  14. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup to disc ratio and its role in pathogenesis. Ophthalmology. 1987;94:1502–8.

    Article  Google Scholar 

  15. Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke. 1993;24:539–42.

    Article  CAS  PubMed  Google Scholar 

  16. Mojan DS, Hedges TR, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120:601–5.

    Article  Google Scholar 

  17. Pomeranz HD, Smith KH, Hart WM Jr, et al. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2002;109:584–7.

    Article  PubMed  Google Scholar 

  18. Campbell UB, et al. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors. J Sex Med. 2015;12:139–51.

    Article  CAS  PubMed  Google Scholar 

  19. Fraunfelder FW, Pomeranz HD, Egan RA. Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch Ophthalmol. 2006;124:733–4.

    Article  PubMed  Google Scholar 

  20. Nathoo NA, et al. Association between phosphdiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2015;35:12–5.

    Article  PubMed  Google Scholar 

  21. Repka MX, Savion PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478–83.

    Article  CAS  PubMed  Google Scholar 

  22. Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol. 1995;15:9–10.

    Article  CAS  PubMed  Google Scholar 

  23. Warner JEA, Lessell S, Rizzo JF, et al. Does optic disc appearance distinguish ischemic optic neuropathy from optic neuritis. Arch Ophthalmol. 1997;115:1408–10.

    Article  CAS  PubMed  Google Scholar 

  24. Friedland S, Winterkorn JM, Burde RM. Luxury perfusion following anterior ischemic optic neuropathy. J Neuroophthalmol. 1996;16:163–71.

    Article  CAS  PubMed  Google Scholar 

  25. Arnold AC, Hepler RS. Natural history of non arteritic ischemic optic neuropathy. J Neuroophthalmol. 1994;14:66–9.

    Article  CAS  PubMed  Google Scholar 

  26. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134:317–28.

    Article  PubMed  Google Scholar 

  27. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115:1818–25.

    Article  PubMed  Google Scholar 

  28. Hayreh SS. Anterior ischemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol. 1974;58:955–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lessell S. Nonarteritic anterior ischemic optic neuropathy: enigma variations (editorial). Arch Ophthalmol. 1999;117:386–8.

    Article  CAS  PubMed  Google Scholar 

  30. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157–63.

    Article  PubMed  Google Scholar 

  31. Galetta SL, Plock GL, Kushner MJ, et al. Ocular thrombosis associated with antiphospholipid antibodies. Ann Ophthalmol. 1991;23:207–12.

    CAS  PubMed  Google Scholar 

  32. Knox DL, Hanneken AM, Hollows FC. Uremic optic neuropathy. Arch Ophthalmol. 1988;106:50–4.

    Article  CAS  PubMed  Google Scholar 

  33. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625–32.

    Article  Google Scholar 

  34. Arnold AC, Helper RS, Lieber M, et al. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;122:535–41.

    Article  CAS  PubMed  Google Scholar 

  35. Botelho PJ, Johnson LN, Arnold AC. The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;121:450–1.

    Article  CAS  PubMed  Google Scholar 

  36. Bennett JL, Thomas S, Olson JL, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroopthalmol. 2007;27:238–40.

    Article  Google Scholar 

  37. Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164–8.

    Article  PubMed  Google Scholar 

  38. Kupersmith MJ, Miller NR. A nonarteritic anterior ischemic optic neuropathy clinical trial: an industry and NORDIC collaboration. J Neuroopthalmol. 2016;36(3):235–7.

    Article  Google Scholar 

  39. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995;113:889–95.

    Article  CAS  PubMed  Google Scholar 

  40. Mansour AM, El-Dairi MA, Shehab MA, et al. Periocular corticosteroids in diabetic papillopathy. Eye. 2005;19:45–51.

    Article  CAS  PubMed  Google Scholar 

  41. Al-Haddad CE, Jurdi FA, Bashshur ZF. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol. 2004;137:1151–3.

    Article  CAS  PubMed  Google Scholar 

  42. Chew SS, Kerr NM, Danesh-Meyer HV. Giant cell arteritis. J Clin Neurosci. 2009;16:1263–8.

    Article  CAS  PubMed  Google Scholar 

  43. Goodman BW. Temporal arteritis. Am J Med. 1979;67:839–53.

    Article  PubMed  Google Scholar 

  44. Liu NH, LaBree LD, Feldon SE, et al. The epidemiology of giant cell arteritis: a 12 year retrospective study. Ophthalmology. 2001;108:1145–9.

    Article  CAS  PubMed  Google Scholar 

  45. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.

    Article  CAS  PubMed  Google Scholar 

  46. ICHD-II. Available at http://ihs-classification.org/en/.

  47. Brass SD, Durand ML, Stone JH, Chen JW, Stone JR. Case records of the Massachusetts General Hospital. Case 36-2008. A 59-year-old man with chronic daily headache. N Engl J Med. 2008;359:2267–78.

    Article  CAS  PubMed  Google Scholar 

  48. Kattah JC, Mejico L, Chrousos GA, et al. Pathologic findings in steroid responsive optic infarct in giant cell arteritis. Neurology. 1999;53:177–80.

    Article  CAS  PubMed  Google Scholar 

  49. McDonnell PJ, Moore GW, Miller NR, et al. Temporal arteritis. A clinicopathologic study. Ophthalmology. 1986;93:518–30.

    Article  CAS  PubMed  Google Scholar 

  50. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical, and prognositic study. Scott Med J. 1979;24:111–7.

    Article  CAS  PubMed  Google Scholar 

  51. Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia rheumatic and giant cell arteritis. N Engl J Med. 2002;347:261–71.

    Article  PubMed  Google Scholar 

  52. Simmons RJ, Cogan DG. Occult temporal arteritis. Arch Ophthalmol. 1962;68:8–18.

    Article  CAS  PubMed  Google Scholar 

  53. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in over 161 patients. Medicine. 2000;79:283–92.

    Article  CAS  PubMed  Google Scholar 

  54. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125:521–6.

    Article  CAS  PubMed  Google Scholar 

  55. Eshaghian J. Controversies regarding giant cell arteritis. Doc Ophthalmol. 1979;47:43–67.

    Article  CAS  PubMed  Google Scholar 

  56. Huna-Baron R, Mizrachi IB, Glovinsky Y. Intraocular pressure is low in eyes with giant cell arteritis. J Neuroophthalmol. 2006;26:273–5.

    Article  PubMed  Google Scholar 

  57. Barricks ME, Traviesa DB, Glaser JS, et al. Ophthalmoplegia in cranial arteritis. Brain. 1977;100:209–21.

    Article  CAS  PubMed  Google Scholar 

  58. El-Dairi MA, Chang L, et al. Diagnostic algorithm for patients with suspected giant cell arteritis. J Neuro-Oncol. 2015;35:246–53.

    Google Scholar 

  59. Hall JK, Volpe NJ, Galetta SL, Liu GT, Syed NA, Balcer LJ. The role of unilateral temporal artery biopsy. Ophthalmology. 2003;110:543–8.

    Article  PubMed  Google Scholar 

  60. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.

    Article  CAS  PubMed  Google Scholar 

  61. Miller NR. Giant cell arteritis. J Neuroophthalmol. 2000;20:219–20.

    Article  CAS  PubMed  Google Scholar 

  62. Lessell S. Bilateral temporal artery biopsies in giant cell arteritis. J Neuroophthalmol. 2000;20:220–1.

    Article  CAS  PubMed  Google Scholar 

  63. Chambers WA, Bernadino VB. Specimen length in temporal artery biopsies. J Clin Neuroophthalmol. 1988;8:121–5.

    Google Scholar 

  64. Jacobson DM, Slamovitz TL. ESR and its relationship to hematocrit in giant cell arteritis. Arch Ophthalmol. 1987;105:965–7.

    Article  CAS  PubMed  Google Scholar 

  65. Hayreh SS, Podhajsky PA, Raman R, et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123:285–96.

    Article  CAS  PubMed  Google Scholar 

  66. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–5.

    Article  PubMed  Google Scholar 

  67. Sadun F, Pece A, Brancato R. Fluorescein and indocyanine green angiography in the diagnosis of giant cell arteritis. Br J Ophthalmol. 1998;82:1344–5.

    Article  CAS  PubMed  Google Scholar 

  68. Landau K, Savino PJ, Gruber P. Diagnosing giant cell arteritis: is ultrasound enough? J Neuroophthalmol. 2013;33:394–400.

    Article  PubMed  Google Scholar 

  69. Chan CC, Paine M, O’Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001;85:1061–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Cornblath WT, Eggenberger ER. Progressive vision loss from giant cell arteritis despite high dose intravenous methylprednisolone. Ophthalmology. 1997;104:854–8.

    Article  CAS  PubMed  Google Scholar 

  71. Clearkin LG. IV steroids for central retinal artery occlusion in giant cell arteritis. Ophthalmology. 1992;99:1482–3.

    Article  CAS  PubMed  Google Scholar 

  72. Hayreh SS, Biousse V. Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids? J Neuroophthalmol. 2012;32:278–87.

    Article  PubMed  Google Scholar 

  73. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patient while on high doses of corticosteroid therapy. Ophthalmology. 2003;110:1204–15.

    Article  PubMed  Google Scholar 

  74. Lessell S. Optic neuropathy in giant cell arteritis. J Neuroophthalmol. 2005;25:247.

    Article  PubMed  Google Scholar 

  75. Kim N, Trobe JD, Flint A, Keoleian G. Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. J Neuroophthalmol. 2003;23:122–6.

    Article  CAS  PubMed  Google Scholar 

  76. Chan CCK, Paine M, O’Day J. Predictors of recurrent ischemic optic neuropathy in giant cell arteritis. J Neuroophthalmol. 2005;25:14–7.

    Article  PubMed  Google Scholar 

  77. Weyand CM, Liao YJ, Goronzy JJ. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol. 2012;32:259–65.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Liu GT, Glaser IS, SCHatz NJ, et al. Visual morbidity in giant cell arteritis: clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779–85.

    Article  CAS  PubMed  Google Scholar 

  79. Rauser M, Rismondo V. Ischemic optic neuropathy during corticosteroid therapy for giant cell arteritis. Arch Ophthalmol. 1995;113:707–8.

    Article  CAS  PubMed  Google Scholar 

  80. Kupersmith MJ, Speira R, Langer R, Richmond M, Peterson M, Speira H, Mitnick H, Paget S. Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthalmol. 2001;21:266–73.

    Article  CAS  PubMed  Google Scholar 

  81. Sadda SR, Nee M, Miller NR, et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:743–50.

    Article  CAS  PubMed  Google Scholar 

  82. Hayreh SS. Posterior ischemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004;18:1188–206.

    Article  CAS  PubMed  Google Scholar 

  83. Gilden DH, Lipton HL, Wolf JS, et al. Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med. 2002;347:1500–3.

    Article  PubMed  Google Scholar 

  84. Harrison EQ. Complications of herpes zoster ophthalmicus. Am J Ophthalmol. 1965;60:1111–4.

    Article  CAS  PubMed  Google Scholar 

  85. Buono LM, Foroozan R. Perioperative posterior ischemic optic neuropathy: review of the literature. Surv Ophthalmol. 2005;50:15–26.

    Article  PubMed  Google Scholar 

  86. Newman NJ. Perioperative vision loss after nonocular surgeries. Am J Ophthalmol. 2008;145:604–10.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Worrell L, Rowe M, Petti G. Amaurosis: a complication of bilateral radical neck dissection. Am J Otolaryngol. 2002;23:56–9.

    Article  PubMed  Google Scholar 

  88. Buono LM, Foroozan R, Savino PJ, et al. Posterior ischemic optic neuropathy after hemodialysis. Ophthalmology. 2003;110:1216–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northern California Kaiser Permanente Medical Group, South San Francisco, CA, USA

    Elizabeth M. Palkovacs

  2. University of Cincinnati & the Cincinnati Eye Institute, Cincinnati, OH, USA

    Karl C. Golnik

Authors
  1. Elizabeth M. Palkovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl C. Golnik
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. L V Prasad Eye Institute, Hyderabad, India

    Preeti Patil Chhablani

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Palkovacs, E.M., Golnik, K.C. (2020). Ischemic Optic Neuropathies: Update. In: Chhablani, P. (eds) Neuro-ophthalmic Disorders. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-8522-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-8522-3_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-8521-6

  • Online ISBN: 978-981-13-8522-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation